SOFT TISSUE SARCOMA

This study tests a new medicine called Risvutatug Rezetecan (Ris-Rez) in adolescents and adults with advanced bone or soft tissue sarcomas that have come back or spread and can't be removed by surgery. The goal is to see if the drug can slow cancer growth and how safe it is. Abou…

This early-stage study tests a new treatment for people with advanced ovarian cancer or other solid tumors that have come back or not responded to standard therapy. The treatment uses a patient's own immune cells that are genetically modified to better recognize and attack cancer…

This study tests a new type of radiation called carbon ion radiotherapy given before surgery for soft tissue sarcoma. The goal is to see if it is safe and can reduce wound problems after surgery while better controlling the tumor. About 60 adults with sarcoma that can be removed …

This study is testing a new AI chatbot designed to answer questions from people with sarcoma, a type of cancer. The chatbot will be available 24/7 by voice or text for one month. Researchers want to see if using the chatbot helps patients feel more satisfied with the information …

This study will enroll 100 children with solid tumors or Hodgkin lymphoma who are receiving proton therapy. Researchers will take weekly or bi-weekly CT or MRI scans during treatment to check if the original radiation plan is still accurate. If tumor coverage drops by 5% or radia…

This very small study will test whether it is practical to add three extra MRI scans during standard radiation treatment for soft tissue sarcoma. Only 5 adults will take part. The goal is simply to see if the extra scans can be completed, not to change treatment or improve outcom…

This observational study looks at how immune checkpoint inhibitors (a type of cancer immunotherapy) affect ovarian function and fertility in women aged 18-38 with solid tumors. Researchers will collect blood and stool samples before and during treatment to measure hormone levels …